Fig. 1From: Efficacy of anti-PD-1/PD-L1 antibodies after discontinuation due to adverse events in non-small cell lung cancer patients (HANSHIN 0316)Kaplan-Meier curves of progression-free survival (PFS). a PFS from the treatment. b PFS from the discontinuationBack to article page